Skip to content

Akero Therapeutics, Inc.: filings

Every Akero Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 26 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2025-11-07fiscal Q3 202532960001193125-25-272569
10-Q2025-08-08fiscal Q2 202532920001193125-25-176038
10-Q2025-05-12fiscal Q1 202533700000950170-25-068563
10-K2025-02-28fiscal FY 202437930000950170-25-029514
10-Q2024-11-08fiscal Q3 2024361050000950170-24-123689
10-Q2024-08-09fiscal Q2 2024361010000950170-24-094347
10-Q2024-05-10fiscal Q1 202436750000950170-24-057458
10-K2024-02-29fiscal FY 202338930000950170-24-022644
10-Q2023-11-13fiscal Q3 2023361050000950170-23-062440
10-Q2023-08-11fiscal Q2 2023361000000950170-23-041554
10-Q2023-05-15fiscal Q1 202336750000950170-23-021968
10-K2023-03-17fiscal FY 202237720000950170-23-008566
10-Q2022-11-04fiscal Q3 2022371040000950170-22-022054
10-Q2022-08-05fiscal Q2 2022361000000950170-22-014904
10-Q2022-05-06fiscal Q1 202230640000950170-22-007990
10-K2022-02-25fiscal FY 202136840001558370-22-002052
10-Q2021-11-12fiscal Q3 202131860001558370-21-015641
10-Q2021-08-13fiscal Q2 202130800001558370-21-011572
10-Q2021-05-13fiscal Q1 202129620001558370-21-006992
10-K2021-03-16fiscal FY 202034610001558370-21-003043
10-Q2020-11-12fiscal Q3 202033850001558370-20-013717
10-Q2020-08-12fiscal Q2 202029770001558370-20-010443
10-Q2020-05-13fiscal Q1 202029610001558370-20-006498
10-K2020-03-16fiscal FY 201930570001558370-20-002798
10-Q2019-11-12fiscal Q3 201926750001558370-19-010680
10-Q2019-08-12fiscal Q2 201825650001104659-19-045178

Inspect the source

Entity
Akero Therapeutics, Inc. / CIK 0001744659
Captured
2026-09-21T17:25:41.770Z
SEC response SHA-256
0ae7d2448decd0f23c1f21654b9424b49076438dd111b2ab06afb1f794330bf1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001744659.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))